CoChat

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

Open access
Mayo, Marlyn J., Carey, Elizabeth, Smith, Helen T., Mospan, Andrea R., McLaughlin, Megan, Thompson, April, Morris, Heather L., Sandefur, Robert, Kim, W. Ray, Bowlus, Christopher, the TARGET-PBC Investigators, Ankoma-Sey, Victor, Bernstein, David, Borg, Brian, Bowlus, Christopher, Brown, Robert, Carey, Elizabeth, Clark, Virginia, Darling, Jama, Dranoff, Jonathan, Elbeshbeshy, Hany, Forman, Lisa, Goel, Aparna, Hanje, James, Harrison, Stephen, Janardhan, Sujit, Jesudoss, Randhir, Kim, David, King, Lindsay, Landis, Charles, Levy, Cynthia, Lok, Anna, Lucey, Michael, Luketic, Velmir, Manch, Richard, Mark, Wong, Mayo, Marlyn, Mena, Edward, Modi, Apurva, Reddy, Gautham, Reddy, K. Rajender, Rochling, Fedja, Rojter, Sergio, Rubin, Raymond, Russo, Mark, Shiffman, Mitchell, Silveira, Marina, Stanca, Carmen, Thuluvath, Paul, Verna, Elizabeth, Weiss, L. Michael, Levy, Cynthia · 2023 · Digestive Diseases and Sciences
Cited by 78

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND AIMS: Patients with primary biliary cholangitis (PBC) often suffer with pruritus. We describe the impact of pruritus on quality of life and how it is managed in a real-world cohort. METHODS: TARGET-PBC is a longitudinal observational cohort of patients with PBC across the USA. Data include information from medical records for three years prior to the date of consent up to 5 years of follow-up. Enrolled patients were asked to complete patient-reported outcome surveys: PBC-40, 5-D itch, and the PROMIS fatigue survey. Kruskal-Wallis tests were used to compare differences in symptoms between groups. RESULTS: A total of 211 patients with completed PRO surveys were included in the current study. PRO respondents were compared with non-respondents in the TARGET-PBC population and were broadly similar. Pruritus was reported in 170 patients (81%), with those reporting clinically significant pruritus (30%) scoring worse across each domain of the PBC-40 and 5-D itch, more frequently having cirrhosis, and having significantly greater levels of fatigue. Patients reporting clinically significant pruritus were more likely to receive treatment, but 33% had never received treatment (no itch = 43.9%, mild itch = 38.3%). CONCLUSIONS: The prevalence of pruritus was high in this population, and those reporting clinically significant pruritus had a higher likelihood of having advanced disease and worse quality of life. However, this study found that pruritus in PBC is under-treated. This may be due in part to ineffectiveness of current treatments, poor tolerance, or the lack of FDA-approved medications for pruritus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10620-022-07581-x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 9

  1. Jones DE et al. An integrated care pathway improves quality of life in primary biliary cirrhosis. QJM: Int J Med 2008;101:535–543. · DOI · Paper page
  2. Hegade VS et al. Pruritus is common and undertreated in patients with primary biliary cholangitis in the United Kingdom. Clin Gastroenterol Hepatol 2019;17:1379–1387. · DOI · Paper page
  3. Levy C et al. A real-world observational cohort of patients with primary biliary cholangitis: target-primary biliary cholangitis study design and rationale. Hepatol Commun 2018;2:484–491. · DOI
  4. Jacoby A et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis. Gut 2005;54:1622–1629. · DOI · Paper page
  5. Elman S et al. The 5-D itch scale: a new measure of pruritus. British J Dermatol 2010;162:587–593. · DOI · Paper page
  6. Al-Harthy N et al. The specificity of fatigue in primary biliary cirrhosis: evaluation of a large clinic practice. Hepatology 2010;52:562–570. · DOI · Paper page
  7. Hegade VS et al. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis. Front Gastroenterol 2016;7:158–166. · DOI · Paper page
  8. Eschler DC, Klein PA. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol: JDD 2010;9:992–997.
  9. Daikeler J, Bošnjak M, Lozar Manfred K. Web versus other survey modes: an updated and extended meta-analysis comparing response rates. J Surv Stat Methodol 2020;8:513–539. · DOI · Paper page

Cited by

See all 78

Metadata

Authors
Mayo, M. J., Carey, E., Smith, H. T., Mospan, A. R., McLaughlin, M., Thompson, A., Morris, H. L., Sandefur, R., Kim, W. R., Bowlus, C., the TARGET-PBC Investigators, Ankoma-Sey, V., Bernstein, D., Borg, B., Bowlus, C., Brown, R., Carey, E., Clark, V., Darling, J., Dranoff, J., Elbeshbeshy, H., Forman, L., Goel, A., Hanje, J., Harrison, S., Janardhan, S., Jesudoss, R., Kim, D., King, L., Landis, C., Levy, C., Lok, A., Lucey, M., Luketic, V., Manch, R., Mark, W., Mayo, M., Mena, E., Modi, A., Reddy, G., Reddy, K. R., Rochling, F., Rojter, S., Rubin, R., Russo, M., Shiffman, M., Silveira, M., Stanca, C., Thuluvath, P., Verna, E., Weiss, L. M., & Levy, C.
Venue
Digestive Diseases and Sciences
Published
2022-06-15
Volume
68
Issue
3
Pages
995-1005
ISSN
  • 0163-2116 (ISSN-L)
  • 1573-2568
OpenAlex
W4282926324
Cited by
78
References
7
FWCI
6.52
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
GlaxoSmithKline (213259)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. https://app.cochat.ai/papers/10.1007/s10620-022-07581-x
The paper
Mayo, M. J., Carey, E., Smith, H. T., Mospan, A. R., McLaughlin, M., Thompson, A., Morris, H. L., Sandefur, R., Kim, W. R., Bowlus, C., the TARGET-PBC Investigators, Ankoma-Sey, V., Bernstein, D., Borg, B., Bowlus, C., Brown, R., Carey, E., Clark, V., Darling, J., . . . Levy, C. (2023). Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-022-07581-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.